TWiV 710: COVID-19 clinical update #46 with Dr. Daniel Griffin
Jan 23, 2021•35 min•Ep. 710
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
In COVID-19 clinical update #46, Daniel Griffin discusses the BinaxNow rapid antigen test, efficacy of Bamlanivimab in nursing homes, associations of serum vitamin D concentrations with in-hospital mortality and need for invasive mechanical ventilation, trials of IL-6 receptor antagonists, effects of anticoagulants on in-hospital mortality, and symptom persistence in outpatients.
Hosts: Daniel Griffin and Vincent Racaniello
Subscribe (free): iTunes, Google Podcasts, RSS, email
Become a patron of TWiV!
Links for this episode- Evaluation of Abbott BinaxNOW (MMWR)
- Lilly mAb in nursing homes (WSJ)
- Vitamin D and COVID-19 severity (Mayo Clin Proc)
- Anticoagulation, aspirin, in-hospital mortality in COVID-19 (medRxiv)
- Long COVID symptoms in outpatients (Ann Int Med)
- Letters read on TWiV 710
- Timestamps by Jolene. Thanks!
Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to daniel@microbe.tv
For the best experience, listen in Metacast app for iOS or Android